"THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"
Completed
This is a randomized, single-blind, placebo controlled trial to evaluate the efficacy of sub-dissociative dose ketamine versus standard care therapy for acute headache management of in patients presenting to the emergency department with headache as the chief compliant.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
01/16/2018
Locations: Brooke Army Medical Center, San Antonio, Texas
Conditions: Headache, Intranasal Ketamine